Form 4: UAMY Director Granted Equity Awards Under Incentive Plan
Insider Transaction Report
United States Antimony Corp. Director John M. Keane received new restricted stock units and stock options under the company's 2023 Equity Incentive Plan.
Summary
- Director John M. Keane was granted 7,464 restricted stock units (RSUs) and stock options for 4,597 shares of common stock.
- These awards were granted on January 15, 2026, under the Issuer's Amended & Restated 2023 Equity Incentive Plan.
- The RSUs and stock options vest in three equal annual installments, beginning January 15, 2027, and continuing on January 18, 2028, and January 16, 2029.
- Vesting is contingent upon Mr. Keane's continued service to the company through each vesting date.
- The stock options have an exercise price of $8.29 per share.
Sentiment
Score: 6
Explanation: The filing reports routine equity compensation for a director, which is generally a neutral to slightly positive event as it aligns interests. There are no negative financial or operational disclosures.
Positives
- The grant of equity awards aligns the director's interests with those of shareholders, incentivizing long-term performance.
- The multi-year vesting schedule encourages continued service and commitment from a key director.
- The awards are part of an existing, approved "Amended & Restated 2023 Equity Incentive Plan," indicating a structured approach to executive compensation.
Risks
- The value of the awards is subject to the future performance of United States Antimony Corp.'s common stock.
- If the stock price falls below the option exercise price of $8.29, the options may become out-of-the-money and lose their intrinsic value.
- The director must maintain continuous service to the company to fully vest in the awards, posing a risk of forfeiture if service terminates prematurely.
Future Outlook
The vesting schedule for the equity awards extends through January 2029, indicating an expectation of continued service from Director John M. Keane and a long-term incentive structure for management.
Industry Context
This Form 4 filing reflects a routine executive compensation event within the mining or materials industry, where equity grants are a common tool to align management incentives with shareholder value. It does not provide specific insights into broader industry trends or competitive positioning beyond the company's internal compensation practices.
Comparison to Industry Standards
- Equity grants with multi-year vesting schedules are standard practice across various industries, including mining and materials, for retaining key personnel and incentivizing long-term performance.
- The specific size of the grant and the exercise price of the options would typically be benchmarked against peer companies of similar size and market capitalization, but such comparative data is not provided in this filing.
Stakeholder Impact
- Shareholders: The equity awards align the director's long-term interests with shareholder value creation, potentially leading to better governance and performance. Dilution from future share issuance upon vesting/exercise is a minor consideration.
- Management: Reinforces the compensation structure for key management/directors, potentially aiding retention.
Next Steps
- The director's continued service will lead to the vesting of RSU and stock option awards on specified future dates (January 15, 2027, January 18, 2028, and January 16, 2029).
- Future Form 4 filings will report the vesting and potential exercise of these awards.
Key Dates
| Date | Description |
|---|---|
| 01/15/2026 | Date of earliest transaction, when RSU and stock option awards were granted. |
| 01/27/2026 | Date the Form 4 was signed by John M. Keane. |
| 01/15/2027 | First vesting date for one-third of the RSU and stock option awards. |
| 01/18/2028 | Second vesting date for an additional one-third of the RSU and stock option awards. |
| 01/16/2029 | Third and final vesting date for the remaining one-third of the RSU and stock option awards. |
Recommendation
holdThis Form 4 filing details a routine equity grant to a director, which is a standard compensation practice aimed at aligning management incentives with shareholder interests. It does not contain information that would fundamentally alter the investment thesis for United States Antimony Corp. Therefore, a 'hold' recommendation is appropriate, as the filing provides no new material information to warrant a change in investment position.
Keywords
United States Antimony Corp, UAMY, Form 4, Insider Trading, Equity Incentive Plan, Restricted Stock Units, Stock Options, Director Compensation, Executive Compensation, Vesting Schedule
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.